Study Evaluating SKI-606 Administered to Healthy Subjects

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: SKI-606

Study type: Interventional

Funder types: Industry

Identifiers

NCT00406406

3160A1-103

Details and patient eligibility

About

Safety and tolerability of SKI-606 in healthy subjects; the influence of food intake on the same.

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind